Award
Delivery Order #SPE2DR26F0E8A
Delivery Order for Enbrel Syringes Under AmerisourceBergen Pharmaceutical Contract
Buyer
Defense Logistics Agency
Award Amount
$18,471.46
Ceiling
$18,471.46
Awarded
March 02, 2026
Period of Performance
Mar 02, 2026 – Mar 03, 2026
Identifier
SPE2DR26F0E8A
NAICS
424210
This award represents a definitive delivery order contract issued to AmerisourceBergen Drug Corp, a prominent pharmaceutical distributor, as part of a broader indefinite delivery vehicle contract focusing on pharmaceutical products. The specific product procured under this award is Enbrel 50 MG/ML syringes, a critical medication used to treat inflammatory conditions. The contract is significant for maintaining a steady and reliable supply of essential pharmaceuticals in support of healthcare agencies and public health infrastructure. The scope of work involves the timely delivery of these specialized syringes to support patient treatment needs. This delivery order was awarded competitively as part of an ongoing multi-year agreement, demonstrating continued trust in the recipient's capability to manage pharmaceutical logistics effectively. The performance period is short-term, covering a couple of days in early March 2026, highlighting a precise, fulfillment-oriented transaction within the contract framework. The award is linked to the parent indefinite delivery vehicle contract, which secures AmerisourceBergen's key role in pharmaceutical supply chains for government healthcare entities.
Description
4571004648!ENBREL 50 MG/ML SYRINGEML